Our Technology

Early Detection Saves Lives

Diving into Our Technology

Our non-intrusive testing, AI-powered cancer detection and patented Cell-CT imaging work together to deliver early detection of lung cancer.

Learn more about our breakthrough technologies below.

Non-Intrusive
Testing

Using Our LuCED® Test Kit

Using AI technology, 3D images are processed to determine if abnormal cells are in your specimen.

How We Collect Your Sample
testing color blocks
Cell CT

3D Cell Imaging

Using Our Patented Cell-CT
Imaging Platform

The Cell-CT images cells in true 3D with submicron-resolution.

Patented Cell-CT Technology

LuCED AI

AI Powered Early Cancer Detection

Through our AI-powered technology, 3D cell images are computed and analyzed to detect abnormal cells in lung cancer. This process is followed up with CellGazer which gives a review of the cell analysis.

VisionGate
Potential

VisionGate’s intellectual property is comprised of 35 patents with 5 more pending.

Please contact us for investment opportunities.

visiongate potentional 35 patents 51 billion